Purchase Order 75F40124P00303
- Not listed
- The Food and Drug Administration (FDA) awarded a $12,173 firm fixed-price purchase order to Nanotemper Technologies Inc., a small disadvantaged business specializing in advanced biophysical analysis instruments. The contract, effective June 11, 2021, with a completion date of July 31, 2023, covers repair services for a Monolith Micro Scale Thermophoresis (MST) system and includes one option period. The award was set aside for total small business participation and is being performed in Silver...
- This contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Nanotemper Technologies Inc., a foreign-owned, self-certified small disadvantaged business. The $144,600 firm-fixed price purchase order is for a Monolith NT.115 Microscale Thermophoresis Instrument, which will be used by the FDA's Center for Biologics Evaluation and Research (CBER) Laboratory of Bacterial Polysaccharides to analyze biological samples and characterize purified...
- The Food and Drug Administration awarded a $149,875 firm fixed-price purchase order to Nanotemper Technologies Inc. for protein stability detection services. The contract, designated as a Total Small Business set aside, was awarded on August 5, 2019, with an ultimate completion date of November 3, 2019. Nanotemper Technologies, a self-certified small disadvantaged business headquartered in South San Francisco, California, will perform the work at its California facility. The company...
- The Department of Health and Human Services Food and Drug Administration awarded a $13,390 purchase order to Nanotemper Technologies Inc. for microscale thermophoresis repair services. Nanotemper will provide the services at its facility in Silver Spring, Maryland under the firm fixed price contract, which runs from September 5, 2023 through September 4, 2024. As the regulatory agency responsible for ensuring the safety and effectiveness of medical devices, the FDA likely requires Nanotemper's...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Nanotemper Technologies Inc., a foreign-owned, self-certified small disadvantaged business. The $12,384.90 contract is for preventative maintenance and repair services for Prometheus instruments. Nanotemper Technologies specializes in advanced biophysical analysis tools and instruments for biomedical research, supporting...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Nanotemper Technologies Inc., a small disadvantaged business, for their Quantifying Molecular Interactions System. The $311,102.00 contract is for the delivery of Nanotemper's proprietary Microscale Thermophoresis (MST) instruments, including the Monolith, Prometheus, Andromeda, and Tycho models, along with associated equipment, training,...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences awarded a Firm Fixed Price purchase order to Nanotemper Technologies Inc., a foreign-owned, self-certified small disadvantaged business, to purchase a NanoTemper Monolith NT.auto system for $324,852.60. The Monolith NT.auto instrument utilizes Nanotemper's proprietary Microscale Thermophoresis (MST) technology to enable the measurement of molecular interactions...
- This is a $13,351 firm-fixed-price purchase order awarded to Nanotemper Technologies Inc., a foreign-owned, self-certified small disadvantaged business, to repair a high-throughput microscale thermophoresis (MST) instrument for the National Center for Advancing Translational Sciences, a civilian agency within the Department of Health and Human Services. The award does not have a set-aside designation. Nanotemper Technologies specializes in advanced biophysical analysis tools and instruments...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Nanotemper Technologies Inc., a foreign-owned, self-certified small disadvantaged business located in South San Francisco, California. The $144,987.00 firm-fixed-price purchase order is for an "Aggregation Analysis System" to support critical biomedical research processes, including molecular interaction...
- The U.S. Food and Drug Administration (FDA) awarded a firm-fixed price purchase order contract valued at $327,080 to Molecular Vista, Inc. to procure an atomic force microscope coupled with photothermal infrared imaging capabilities. This acquisition, made under the FDA's Office of Acquisition and Grants Services, responds to a request for quotations seeking a system to physically and chemically characterize nanomaterials in drug products at the nanoscale level. As a total small business...
The Food and Drug Administration (FDA) awarded a one-year service contract to Nanotemper Technologies Inc. on September 5, 2024, for the provision and maintenance of Monolith Micro Scale Thermophoresis (MST) equipment, valued at $15,411.20. This firm fixed-price purchase order, with an ultimate completion date of September 22, 2025, will be performed at the FDA's Silver Spring, Maryland facility. The contract carries no small business set-aside designation. Nanotemper Technologies, a foreign-owned, self-certified small disadvantaged business headquartered in South San Francisco, California, specializes in advanced biophysical analysis instrumentation for biomedical research and regulatory support applications. The MST system procured under this contract supports the FDA's critical research and regulatory review functions by enabling precise molecular interaction analysis and protein characterization. Nanotemper Technologies has an established contracting relationship with the FDA and other Department of Health and Human Services agencies, consistently delivering specialized scientific instruments and related services including preventative maintenance, repairs, and technical training. This award reflects the FDA's continued investment in advanced analytical capabilities necessary for drug development evaluation and scientific research processes that inform regulatory decision-making.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 9/23/25 | |
| Not listed | Not listed | $15.4k | 7/16/24 |